| Very early onset inflammatory bowel disease: a clinical approach with a focus on the role of genetics and underlying immune deficiencies J Ouahed, E Spencer, D Kotlarz, DS Shouval, M Kowalik, K Peng, M Field, ... Inflammatory bowel diseases 26 (6), 820-842, 2020 | 137 | 2020 |
| Approach to the management of recently diagnosed inflammatory bowel disease patients: a user’s guide for adult and pediatric gastroenterologists M Agrawal, EA Spencer, JF Colombel, RC Ungaro Gastroenterology 161 (1), 47-65, 2021 | 124 | 2021 |
| Dual biologic and small molecule therapy for the treatment of refractory pediatric inflammatory bowel disease MT Dolinger, EA Spencer, J Lai, D Dunkin, MC Dubinsky Inflammatory bowel diseases 27 (8), 1210-1214, 2021 | 63 | 2021 |
| Failure to achieve target drug concentrations during induction and not HLA-DQA1∗ 05 carriage is associated with antidrug antibody formation in patients with inflammatory bowel … EA Spencer, J Stachelski, T Dervieux, MC Dubinsky Gastroenterology 162 (6), 1746-1748. e3, 2022 | 28 | 2022 |
| Fecal microbiota transplant for recurrent Clostridium difficile infection in pediatric inflammatory bowel disease S Cho, E Spencer, R Hirten, A Grinspan, MC Dubinsky Journal of Pediatric Gastroenterology and Nutrition 68 (3), 343-347, 2019 | 26 | 2019 |
| Seroconversion following SARS-CoV-2 infection or vaccination in pediatric IBD patients EA Spencer, E Klang, M Dolinger, N Pittman, MC Dubinsky Inflammatory bowel diseases 27 (11), 1862-1864, 2021 | 23 | 2021 |
| De novo Crohn's disease of the pouch in children undergoing ileal pouch-anal anastomosis for ulcerative colitis L Jarchin, EA Spencer, S Khaitov, A Greenstein, J Jossen, J Lai, D Dunkin, ... Journal of pediatric gastroenterology and nutrition 69 (4), 455-460, 2019 | 23 | 2019 |
| Serologic reactivity reflects clinical expression of ulcerative colitis in children EA Spencer, SM Davis, DR Mack, BM Boyle, AM Griffiths, NS LeLeiko, ... Inflammatory bowel diseases 24 (6), 1335-1343, 2018 | 18 | 2018 |
| Therapeutic drug monitoring in inflammatory bowel disease: history and future directions EA Spencer, MC Dubinsky Pediatric Clinics 64 (6), 1309-1326, 2017 | 18 | 2017 |
| Outcomes of primary ileocolic resection for pediatric Crohn disease in the biologic era EA Spencer, L Jarchin, P Rolfes, S Khaitov, A Greenstein, MC Dubinsky Journal of pediatric gastroenterology and nutrition 73 (6), 710-716, 2021 | 10 | 2021 |
| The impact of thiopurine metabolite monitoring on the durability of thiopurine monotherapy in pediatric IBD E Spencer, E Norris, C Williams, MC Dubinsky Inflammatory Bowel Diseases 25 (1), 142-149, 2019 | 10 | 2019 |
| Outcomes of children with inflammatory bowel disease who develop anti-tumour necrosis factor-induced skin reactions MT Dolinger, P Rolfes, E Spencer, G Stoffels, D Dunkin, MC Dubinsky Journal of Crohn's and Colitis 16 (9), 1420-1427, 2022 | 7 | 2022 |
| Precision medicine in pediatric inflammatory bowel disease EA Spencer, MC Dubinsky Pediatric Clinics 68 (6), 1171-1190, 2021 | 7 | 2021 |
| Inflammatory bowel disease clusters within affected sibships in Ashkenazi Jewish multiplex families EA Spencer, D Helmus, S Telesco, JF Colombel, MC Dubinsky Gastroenterology 159 (1), 381-382, 2020 | 7 | 2020 |
| Early Intestinal Ultrasound Response to Biologic Therapy Predicts Endoscopic Remission in Children with Ileal Crohn’s Disease: Results from the Prospective Super Sonic Study MT Dolinger, I Aronskyy, A Kellar, E Spencer, N Pittman, MC Dubinsky Journal of Crohn's and Colitis, jjad216, 2023 | 5 | 2023 |
| Barriers to optimizing inflammatory bowel disease care in the United States EA Spencer, S Abbasi, M Kayal Therapeutic Advances in Gastroenterology 16, 17562848231169652, 2023 | 5 | 2023 |
| Net remission rates with biologic and small molecule treatment in ulcerative colitis: a reappraisal of the clinical trial data M Kayal, H Posner, E Spencer, JF Colombel, C Stalgis, RC Ungaro Clinical Gastroenterology and Hepatology 21 (13), 3433-3436. e1, 2023 | 4 | 2023 |
| A single-center experience with Dupilumab for atopic or psoriasiform dermatitis in patients with inflammatory bowel disease EA Spencer, MT Dolinger, MC Dubinsky Digestive Diseases and Sciences 68 (4), 1121-1124, 2023 | 4 | 2023 |
| Dop72 HLA-Dqa1* 05 Associates with Immunogenicity and loss of response to anti-TNF therapy in the IBD population: A meta-analysis S Bergstein, EA Spencer Journal of Crohn's and Colitis 17 (Supplement_1), i148-i150, 2023 | 4 | 2023 |
| Determining the accuracy of intestinal ultrasound scores as a pre-screening tool in Crohn’s disease clinical trials MT Dolinger, I Aronskyy, A Kellar, M Gao, EA Spencer, N Pittman, ... Official journal of the American College of Gastroenterology| ACG, 10.14309, 2022 | 3 | 2022 |
